search query: @indexterm new products / total: 1069
reference: 466 / 1069
« previous | next »
Author:Fitzgerald, J. D.
Title:Technology transfer issues in licensing pharmaceutical products
Journal:R. and D. Management
1992 : JUL, VOL. 22:3, p.199-208
Index terms:TECHNOLOGY TRANSFER
PHARMACEUTICAL INDUSTRY
PRODUCTS
NEW PRODUCTS
LICENSING
Language:eng
Abstract:The discovery and development of a new therapeutic agent may take five to ten years, a large amount of money with a significant risk of product failure, due either to lack of safety or efficacy. Pharmaceutical companies require a new product every three to five years in order to sustain growth. This need is often met by licensing a product from a competitor. It is shown that the evaluation of a potential licensing oportunity is a complex task in technology transfer. The main activities involved in the evaluation process are described. Some problems in technology transfer which include organizational, attitudinal and behavioural factors are examined. Possible topics for future research are identified.
SCIMA record nr: 107734
add to basket
« previous | next »
SCIMA